Thrombin promotes proinflammatory phenotype in human vascular smooth muscle cell

Sung-Woon Chung1, Jae-Woo Park, Sae-A Lee

  • 1Department of Thoracic and Cardiovascular Surgery, School of Medicine, Pusan National University, Busan, Republic of Korea.

Insights

Thrombin signaling promotes a proinflammatory phenotype in human vascular smooth muscle cells (VSMC). This process involves key signaling pathways like PI3K/Akt, PKC, and MAPK, contributing to vascular inflammation.

Area of Science:

  • Vascular Biology
  • Cell Signaling
  • Immunology

Background:

  • Protease-activated receptor (PAR), the thrombin receptor, is upregulated in atherosclerotic plaques.
  • VSMC phenotypic switching to proinflammatory states is a hallmark of atherosclerosis.

Purpose of the Study:

  • To investigate if thrombin induces a proinflammatory phenotype in human aortic smooth muscle cells (HAoSMC).
  • To identify the signaling pathways mediating thrombin's effects on VSMC.

Main Methods:

  • Quantitative PCR to measure gene transcripts (IL-6, CXCL8, CCL11).
  • ELISA to quantify protein release of IL-6 and CXCL8.
  • Western blotting to assess activation of Akt, PKC, and MAPK.
  • Pharmacological inhibition of signaling pathways (PI3K, Akt, PKC, NADPH oxidase, MAPK).

Main Results:

  • Thrombin significantly increased IL-6, CXCL8, and CCL11 gene expression in HAoSMC.
  • Thrombin enhanced the release of IL-6 and CXCL8 proteins.
  • Thrombin activated Akt, PKC, and MAPK signaling pathways.
  • Inhibitors of PI3K/Akt, PKC, NADPH oxidase, and MAPK attenuated thrombin-induced IL-6 and CXCL8 production.

Conclusions:

  • Thrombin promotes a proinflammatory phenotype in human VSMC.
  • PI3K, Akt, PKC, NADPH oxidase, and MAPK signaling pathways are crucial mediators of thrombin's proinflammatory effects.
  • Thrombin-induced VSMC activation may exacerbate vascular inflammation following endothelial injury or thrombus formation.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...